expectations for pfizer have been low, says mizuho's jared holz on weight-loss pill setback
Published 9 months ago • 16K plays • Length 5:52Download video MP4
Download video MP3
Similar videos
-
5:05
pfizer is far behind weight loss drug race despite pill trial, says mizuho's jared holz
-
0:55
pfizer ceo: weight loss pill may enter regulatory studies next year
-
5:05
amgen has 'a lot to prove' in the weight-loss drug category, says mizuho's jared holz
-
0:50
pfizer moves forward with once-daily version of weight-loss pill after setbacks
-
6:09
inflation is on 'back burner' to labor market: strategist
-
8:16
rethinking obesity & weight loss: how taking ozempic changed author johann hari's life
-
28:21
which 3 stocks should you buy? | ko vs pep, de vs cat, jnj vs mrk
-
4:01
pfizer's weight loss pill may enter regulatory studies next year, says ceo albert bourla
-
2:10
pfizer advances development of once-daily formulation of oral weight loss pill
-
3:33
pfizer pill approval news already priced into stock: oppenheimer's jared holz
-
5:13
obesity drug enthusiasm can continue in 2024: mizuho's jared holz
-
2:08
pfizer stock drops after company picks twice-daily weight loss pill candidate
-
5:26
obesity drug supply-demand imbalance is working in novo nordisk's favor: mizuho's jared holz
-
4:13
mizuho's jared holz on finding opportunities in the biotech space
-
0:29
barbra sasu: what we’re working on
-
2:51
pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
-
4:01
pfizer's weight-loss pill won't be in direct competition with ozempic, says bmo's evan seigerman
-
2:10
pfizer shares sink on weak 2024 revenue, profit forecasts
-
0:31
albert kim: what we’re working on
-
3:46
josh brown buys more pfizer
-
1:30
pfizer beats eps estimates; stock falls on lower yearly guidance
-
7:09
a biotech self-correction is in store, says oppenheimer's jared holz